The $121 billion will come from drug companies, insurance companies and medical device manufacturers in order to help fund the expansion of health coverage, according to the report.
The Committee’s most recent estimates are higher than previous ones because the previous estimates assumed companies could deduct the fees from their corporate taxes, which the current plan will not allow.
The Committee’s senior member, Sen. Charles Grassley (R-Iowa), said the higher taxes would be “passed on to consumers in the form of higher premiums and healthcare costs,” according to the report.
Read the Reuters’ report on health company fees.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
